An evaluation of nano-hydroxyapatite as a pulpotomy medicament in primary teeth.

Dr Monika Grewal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•symptom-free deep carious mandibular primary molar tooth with vital pulp,
•sufï¬?cient tooth structure for restoration with a stainless steel crown,
•no history of spontaneous pain,
•no clinical evidence of extensive pulp degeneration or periapical pathology,including tenderness to percussion, tooth mobility, abscess, ï¬?stula, or swelling of the gingiva,
•no radiographic evidence of periapical pathosis or inter-radicular bone loss,internal resorption, pulp calcification, ankylosis, or pathologic external root resorption.
•Physiologic root resorption, while included in the criteria, could not be more than one-third of the root length.

•Exclusion criteria included the presence of any systemic pathology
•any history of allergic reaction to latex, local anesthetics or to the constituents of the tested pulp dressing agents.
•Clinical or radiographic sign or symptoms of pulp degeneration(i.e. spontaneous pain, excessive bleeding from the root canal,inter-radicular and/or periapical bone destruction)

发起方

Dr Monika Grewal